| DANCANN PHARMA DK 1 |
| Dänemark |
| Gesundheit |
| DK0063631999 / A412SL |
| DAN0 (Frankfurt) |
| FRA:DAN0, ETR:DAN0, DAN0:GR |
| - |
| https://www.dancann.com/ |
|
DanCann Pharma A/S is a Danish biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of therapeutic cannabinoids. Established in 2018 and based in Ansager, Denmark, it focuses primarily on cannabin..
>Volltext.. |
| 0.11 Mio. EUR |
| 0.04 Mio. EUR |
| 0.59 Mio. EUR |
| -0.96 Mio. EUR |
| -1.26 Mio. EUR |
| -0.38 EUR |
| - |
| 0.07 Mio. EUR |
| -0.48 Mio. EUR |
| 0.09 |
| -45.24% |
| -4.51% |
| - |
| - |
| - |
| - |
| DANCANN |
| 01.04.26 |
|